These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Posterior reversible encephalopathy syndrome in a patient with multiple myeloma treated with thalidomide. Chow S; Cheung CS; Lee DH; Howson-Jan K; Xenocostas A Leuk Lymphoma; 2012 May; 53(5):1003-5. PubMed ID: 22054288 [No Abstract] [Full Text] [Related]
51. Lenalidomide and its role in the management of multiple myeloma. Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796 [TBL] [Abstract][Full Text] [Related]
52. [Efficacy of thalidomide combined dexamethasone on newly diagnosed multiple myeloma]. Yuan ZG; Hou J; Wang DX; Fu WJ; Chen YB; Xi H Ai Zheng; 2007 Dec; 26(12):1369-72. PubMed ID: 18076804 [TBL] [Abstract][Full Text] [Related]
53. Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide. Srinivasan S; Schiffer CA Leuk Res; 2009 Apr; 33(4):561-4. PubMed ID: 18676017 [TBL] [Abstract][Full Text] [Related]
54. Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure. Spencer A; Prince HM; Roberts AW; Prosser IW; Bradstock KF; Coyle L; Gill DS; Horvath N; Reynolds J; Kennedy N J Clin Oncol; 2009 Apr; 27(11):1788-93. PubMed ID: 19273705 [TBL] [Abstract][Full Text] [Related]
55. Encephalopathy in a patient after long-term treatment with thalidomide. Sohlbach K; Heinze S; Shiratori K; Sure U; Pagenstecher A; Neubauer A J Clin Oncol; 2006 Oct; 24(30):4942-4. PubMed ID: 17050881 [No Abstract] [Full Text] [Related]
56. Thalidomide and thrombosis in multiple myeloma. Barbui T; Falanga A J Thromb Haemost; 2003 Mar; 1(3):421-2. PubMed ID: 12871443 [No Abstract] [Full Text] [Related]
57. [Picture in clinical hematology no.42]. Saito M; Mori A; Irie T; Tanaka M; Morioka M Rinsho Ketsueki; 2010 Mar; 51(3):165. PubMed ID: 20379109 [No Abstract] [Full Text] [Related]
58. Thalidomide-induced fulminant hepatic failure. Hamadani M; Benson DM; Copelan EA Mayo Clin Proc; 2007 May; 82(5):638. PubMed ID: 17493431 [No Abstract] [Full Text] [Related]
59. The addition of liposomal doxorubicin to bortezomib, thalidomide and dexamethasone significantly improves clinical outcome of advanced multiple myeloma. Ciolli S; Leoni F; Casini C; Breschi C; Santini V; Bosi A Br J Haematol; 2008 Jun; 141(6):814-9. PubMed ID: 18410447 [TBL] [Abstract][Full Text] [Related]
60. Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome? Katodritou E; Gastari V; Verrou E; Hadjiaggelidou C; Varthaliti M; Georgiadou S; Laschos K; Xirou P; Yiannaki E; Constantinou N; Markala D; Zervas K Leuk Res; 2009 Aug; 33(8):1137-40. PubMed ID: 19250676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]